Warning letter
Prodigy Diabetes Care, LLC: warning letter of Feb 22, 2013
FDA warning letter 323225 · Atlanta District Office
Key facts
| Reference number | 323225 |
|---|---|
| Company | Prodigy Diabetes Care, LLC |
| Subject | Medical Device Reporting/Misbranded |
| Issue date | Feb 22, 2013 |
| Posted date | Feb 22, 2013 |
| Issuing office | Atlanta District Office |
| Product type | Devices |
| CFR sections cited | 803.50(b), 803, 803.3, 803.17, 803.50(a)(1), 820, 820.40 |
| Inspection city | huntersville |
| Inspection ZIP | 28078 |
| Inspection start date | Mar 5, 2012 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: